TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 61 filers reported holding TFF PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 3.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,475 | -25.5% | 69,929 | 0.0% | 0.00% | – |
Q2 2023 | $32,867 | -31.4% | 69,929 | 0.0% | 0.00% | – |
Q1 2023 | $47,922 | -67.4% | 69,929 | -50.0% | 0.00% | – |
Q4 2022 | $146,850 | -48.3% | 139,858 | +100.0% | 0.00% | – |
Q3 2022 | $284,000 | -28.1% | 69,929 | 0.0% | 0.00% | – |
Q2 2022 | $395,000 | -10.4% | 69,929 | 0.0% | 0.00% | – |
Q1 2022 | $441,000 | -23.2% | 69,929 | +8.1% | 0.00% | – |
Q4 2021 | $574,000 | +69.3% | 64,678 | +47.4% | 0.00% | – |
Q3 2021 | $339,000 | -19.7% | 43,878 | 0.0% | 0.00% | – |
Q2 2021 | $422,000 | – | 43,878 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,565,682 | $21,246,000 | 7.82% |
APIS CAPITAL ADVISORS, LLC | 182,500 | $2,477,000 | 2.25% |
Altium Capital Management LP | 269,691 | $3,660,000 | 1.02% |
Mesirow Financial Investment Management, Inc. | 27,216 | $369,000 | 1.00% |
PRECEPT MANAGEMENT LLC | 107,300 | $1,456,000 | 0.99% |
Gagnon Advisors, LLC | 176,471 | $2,395,000 | 0.99% |
GAGNON SECURITIES LLC | 377,976 | $5,129,000 | 0.78% |
P.A.W. CAPITAL CORP | 63,695 | $864,000 | 0.76% |
Diametric Capital, LP | 32,868 | $446,000 | 0.34% |
DRW Securities, LLC | 513,400 | $6,967,000 | 0.28% |